Morgan Stanley MS, will be reporting its fourth-quarter earnings on Jan. 16. Wall Street expects the company to announce 99 cents in EPS and $11.61 billion in revenues as it reports before market hours.
The financial sector firm is known for its presence across investment banking, securities trading, wealth management, and asset management, at a global level. Morgan Stanley’s diversified revenue streams, unique lending operations, and conservative financial structure position it as a notable player in the financial sector.
However, Morgan Stanley’s stock has underperformed the broad market SPY by 16% in 2023. For the past year, it has lagged most of its peers, except Charles Schwab Corp SCHW and Raymond James Financial RJF.
As the company reports Q4 2023 earnings, here's what analysts will be focusing on, and how the stock currently maps against Wall Street estimates.
Business & Fundamentals: Morgan Stanley’s revenue structure is marked by a notable presence in trading operations, contributing 28.05%, and a substantial share from asset management at 36.30%. While these segments are sensitive to market fluctuations, the company’s diversified revenue streams position it as a resilient player in the volatile financial markets.
Morgan Stanley’s financial structure reflects a conservative stance on debt, with an annual growth rate of 4.4%. Concurrently, the institution has bolstered its cash reserves by an impressive 56.1% annually, surpassing the growth in debt.
The firm earns interest through lending operations, with a distinct focus on stock-based loans and residential mortgages. This strategic approach sets Morgan Stanley apart from its peers, showcasing a nuanced understanding of the financial sector and allowing for flexibility in response to market dynamics.
Also Read: Morgan Stanley Is Expected To Resolve Block Trade Investigation With Multi-Million Dollar Payment
Q4 Analysts' Focus: While market-sensitive segments bring inherent volatility, the company’s effective debt management strategies and strong financial results present it as a potentially attractive investment option. However, it remains to be seen if Morgan Stanley can sustain this resilience throughout the year, a factor analysts will be closely monitoring.
Ratings & Consensus Estimates: Consensus analyst ratings for MS stock currently stand at Neutral with a price target of $86.36. However, analyst reviews, published this month, paint a better picture for the stock.
UBS, JPMorgan and HSBC, who published their reviews on Jan. 9 have a price target of $95, $94 and $96, respectively on Morgan Stanley’s stock. BofA Securities rated the stock a Buy with a price target on $100 on Jan. 4 and Barclays rated the stock Overweight with a price target of $116 on Jan. 2.
Price Action: Morgan Stanley stock closed 0.89 lower on Friday at $89.70.
Read Next: Funding The Future: Morgan Stanley’s $1.7 Million Injection Into Startup Ecosystem
Photo: Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
